Novyra Pharmachem Other Announcement
Novyra Pharmachem intimated BSE of a change in its official email ID under Reg 30. The update is purely administrative with no business or financial impact.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Novyra Pharmachem intimated BSE of a change in its official email ID under Reg 30. The update is purely administrative with no business or financial impact.
The company has officially changed its name from Bansisons Tea Industries Limited to Novyra Pharmachem Limited. This change reflects the company's expansion into the pharmaceutical sector.
Bansisons Tea Industries Ltd reported revenue from operations of ₹1.7 Cr and net profit of ₹0 Cr for Q1 FY27.
Novyra Pharmachem Limited has scheduled a board meeting for August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Novyra Pharmachem Limited has updated its official website address. The change is being intimated to the exchange for record-keeping purposes.
Bansisons Tea Industries Ltd has submitted its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI Regulation 31(1)(b).